Ratings by Jefferies (Eun Yang)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/24/2023 | Paratek Pharmaceuticals | PRTK | Maintain | Buy (N/A) |
|
Details | ||
| 1/11/2023 | Albireo Pharma | ALBO | Downgrade | Hold (Buy) |
43.85 (44.10) |
0.57% | Details | |
| 1/9/2023 | CureVac | CVAC | Maintain | Buy (Hold) |
|
Details | ||
| 12/16/2022 | Astria Therapeutics | ATXS | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2022 | Lumos Pharma | LUMO | Downgrade | Hold (Buy) |
4.83 (3.55) |
-26.5% | Details | |
| 11/14/2022 | Lumos Pharma | LUMO | Downgrade | Hold (Buy) |
8.91 (3.55) |
-60.16% | Details | |
| 11/14/2022 | Prime Medicine | PRME | New Coverage | Buy (N/A) |
20.57 (16.97) |
-17.5% | Details | |
| 11/9/2022 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | Rallybio Corp. | RLYB | Maintain | Buy (N/A) |
|
Details | ||
| 9/22/2022 | NuCana | NCNA | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2022 | Rigel Pharmaceuticals | RIGL | Downgrade | Hold (Buy) |
1.76 (1.65) |
-6.25% | Details | |
| 5/24/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2022 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2022 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 12/27/2021 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2021 | Pyxis Oncology Inc. | PYXS | New Coverage | Buy (N/A) |
13.34 (1.56) |
-88.31% | Details | |
| 10/20/2021 | Radius Health | RDUS | Maintain | Hold (N/A) |
|
Details | ||
| 10/4/2021 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2021 | Astria Therapeutics | ATXS | New Coverage | Buy (N/A) |
9.53 (13.49) |
41.55% | Details | |
| 8/23/2021 | Rallybio Corp. | RLYB | New Coverage | Buy (N/A) |
12.92 (6.90) |
-46.59% | Details | |
| 8/3/2021 | Translate Bio | TBIO | Downgrade | Hold (Buy) |
29.15 (1.82) |
-93.76% | Details | |
| 7/26/2021 | Aerovate Therapeutics Inc | AVTE | New Coverage | Buy (N/A) |
14.23 (23.69) |
66.48% | Details | |
| 7/15/2021 | Generation Bio | GBIO | Maintain | Buy (N/A) |
|
Details | ||
| 7/12/2021 | Verve Therapeutics | VERV | New Coverage | Buy (N/A) |
46.25 (21.77) |
-52.93% | Details | |
| 7/8/2021 | Nabriva Therapeutics AG | NBRV | New Coverage | Hold (N/A) |
1.27 (1.55) |
22.05% | Details | |
| 6/22/2021 | Centessa Pharmaceuticals | CNTA | New Coverage | Buy (N/A) |
24.91 (3.81) |
-84.7% | Details | |
| 6/9/2021 | Cogent | COGT | New Coverage | Buy (N/A) |
7.85 (14.36) |
82.93% | Details | |
| 5/11/2021 | Taysha Gene Therapies | TSHA | New Coverage | Buy (N/A) |
20.52 (1.54) |
-92.5% | Details | |
| 5/11/2021 | Biomea Fusion Inc. | BMEA | New Coverage | Buy (N/A) |
16.94 (9.69) |
-42.8% | Details | |
| 5/4/2021 | Reneo Pharmaceuticals | RPHM | New Coverage | Buy (N/A) |
14.40 (2.70) |
-81.25% | Details | |
| 4/8/2021 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2021 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2021 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2021 | Five Prime Therapeutics | FPRX | Downgrade | Hold (Buy) |
21.26 (38.00) |
78.74% | Details | |
| 3/2/2021 | Paratek Pharmaceuticals | PRTK | New Coverage | Buy (N/A) |
7.48 (2.07) |
-72.33% | Details | |
| 1/27/2021 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2020 | Dyne Therapeutics | DYN | New Coverage | Buy (N/A) |
18.99 (14.61) |
-23.06% | Details | |
| 9/8/2020 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2020 | CureVac | CVAC | New Coverage | Hold (N/A) |
56.92 (11.58) |
-79.66% | Details | |
| 8/14/2020 | Lumos Pharma | LUMO | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | Radius Health | RDUS | Maintain | Hold (N/A) |
|
Details | ||
| 8/11/2020 | Halozyme Therapeutics | HALO | Maintain | Underperform (N/A) |
|
Details | ||
| 8/7/2020 | Translate Bio | TBIO | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2020 | Generation Bio | GBIO | New Coverage | Buy (N/A) |
19.56 (6.20) |
-68.3% | Details | |
| 5/18/2020 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2020 | Deciphera | DCPH | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2020 | Halozyme Therapeutics | HALO | Maintain | Underperform (N/A) |
|
Details | ||
| 4/16/2020 | Lumos Pharma | LUMO | New Coverage | Buy (N/A) |
9.21 (3.55) |
-61.45% | Details | |
| 3/10/2020 | United Therapeutics Corp. | UTHR | Upgrade | Buy (Hold) |
98.26 (258.71) |
163.29% | Details | |
| 3/10/2020 | United Therapeutics Corp. | UTHR | Upgrade | Buy (Hold) |
98.26 (258.71) |
163.29% | Details | |
| 10/16/2019 | Alexion Pharmaceuticals | ALXN | Maintain | Hold (N/A) |
|
Details | ||
| 9/30/2019 | Deciphera | DCPH | New Coverage | Buy (N/A) |
32.86 (17.04) |
-48.14% | Details | |
| 8/1/2019 | United Therapeutics Corp. | UTHR | Upgrade | Hold (Underperform) |
79.53 (258.71) |
225.3% | Details | |
| 7/23/2019 | Ionis Pharmaceuticals | IONS | Maintain | Underperform (N/A) |
|
Details | ||
| 7/22/2019 | Translate Bio | TBIO | New Coverage | Buy (N/A) |
9.60 (29.15) |
203.65% | Details | |
| 7/22/2019 | BridgeBio Pharma | BBIO | New Coverage | Buy (N/A) |
26.00 (8.95) |
-65.58% | Details | |
| 6/18/2019 | Ra Pharma | RARX | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2019 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2019 | Array BioPharma | ARRY | Downgrade | Hold (Buy) |
29.59 (21.25) |
-28.19% | Details | |
| 5/28/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2019 | Array BioPharma | ARRY | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2019 | La Jolla Pharma | LJPC | Upgrade | Hold (Underperform) |
6.10 (6.22) |
1.97% | Details | |
| 12/20/2018 | DBV Technologies S.A | DBVT | Downgrade | Hold (Buy) |
14.69 (1.35) |
-90.81% | Details | |
| 10/30/2018 | Array BioPharma | ARRY | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2018 | AMAG Pharmaceuticals | AMAG | Maintain | Hold (N/A) |
|
Details |
